Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin.
Phase of Trial: Phase II
Latest Information Update: 18 Jul 2014
At a glance
- Drugs Exenatide (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Bristol-Myers Squibb
- 07 Jun 2017 Biomarkers information updated
- 07 Jun 2011 Planned End Date changed from 1 Oct 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 13 Dec 2010 Planned end date changed from 1 Oct 2010 to 1 Oct 2011 as reported by ClinicalTrials.gov.